Ad
related to: novavax vaccine
Search results
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 14 hours agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 14 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Novavax’s R&D head, integral to Covid vaccine work, to retire - Washington Business Journal
The Business Journals· 5 days agoThe head of research and development at Novavax Inc., a key player in the development of its...
Smart Money Is Betting Big In NVAX Options - Novavax (NASDAQ:NVAX)
Benzinga· 6 days agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks via Yahoo Finance· 7 days agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 6 days agoThe three vaccines updated to target the SARS-CoV-2 XBB.1.5 subvariant -- Moderna's and Pfizer-BioNTech's mRNA vaccines and the Novavax
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 6 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 4 days agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...
Growth Stocks to Avoid Like the Plague: 3 Overpriced Picks Primed to Plummet
InvestorPlace· 3 days agoGrowth stocks can be millionaire-makers and the same ideas can be destroyers of wealth. The...